Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBS2_Supporting
The NM_001142616.3(EHBP1):c.105-4G>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00318 in 1,605,240 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).
EHBP1 (HGNC:29144): (EH domain binding protein 1) This gene encodes an Eps15 homology domain binding protein. The encoded protein may play a role in endocytic trafficking. A single nucleotide polymorphism in this gene is associated with an aggressive form of prostate cancer. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 2-62747391-G-C is Benign according to our data. Variant chr2-62747391-G-C is described in ClinVar as [Benign]. Clinvar id is 779224.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 425 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.